ERGOCRYSTINE MESYLATE

Ergocrystine mesylate provides similar ergot effects for hormonal and vascular conditions. Side effects include vasoconstriction, paresthesias, and GI upset.

SKU: f52632a914f4 Category: Tag:

Product Description


Mechanism of Action

Ergocrystine mesylate is a mesylate salt form of ergocrystine that improves solubility and handling. Mechanistically it retains the mixed dopaminergic, serotonergic and adrenergic receptor interactions of the parent base, modulating vascular tone and central neurotransmission.

Benefits and Advantages

Used where enhanced solubility is needed for ergot‑receptor binding assays, vascular‑pharmacology studies, and formulation development in ergot‑alkaloid research.

Side Effects and Risks

Risks mirror other ergot derivatives: vasospasm, ischemia, nausea, paresthesias and potential fibrosis with prolonged high exposure. Handle under ergot‑alkaloid safety protocols.

Datasheet


Molecular Formula

C35H39N5O5·CH4O3S

Molecular Weight

655.74 g/mol

CAS Number

2149-68-4

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

IUPAC/Chemical Name

Mesylate salt of ergocristine

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download